Key Takeaways
- Margin recovery takes hold: EBITDA margin jumped from 4.5% to 8.84% QoQ, driven by better spreads in manufacturing and distribution, with management targeting a return to the typical 10% for the year.
- Manufacturing exports drive the top line: Manufacturing revenue rose ~13% QoQ on a 46% volume surge in Acrylamide Liquid exports, aided by EU REACH registration opening new geographies and customers.
- Distribution revenue hit by price and demand: Falling chemical prices and recessionary pressure from the U.S. oil and gas sector pulled distribution revenue down QoQ, though margins still improved slightly.
- New product pipeline is advancing, not yet contributing: NMA won foreign approvals and orders, Polyacrylamide Solids development progressed, and two toll manufacturing projects were secured, but material revenue contribution lies in future quarters.
- What to watch next quarter: Whether raw material price stabilization flows into better realizations, the pace of NMA volume ramp-up from new customer approvals, and any progress on the antidumping application for Acrylamide.
Manufacturing Segment: Export-Led Volume Growth
- Acrylamide Liquid exports surged: Volume increased 46% QoQ, with better price realizations from export markets lifting both revenue and EBITDA for the manufacturing division.
- EU REACH registration unlocked Europe: The registration is providing deeper penetration into the European market, bringing in new customers and new geographical areas.
- KKDIK REACH applied for Turkey: The company has applied for the Turkish REACH equivalent to secure more orders from that region, extending the export-driven strategy.
- Chinese dumping persists in India: Dumping by Chinese suppliers for Acrylamide powder continues unabated as domestic demand in China has not picked up, hampering sales of both Acrylamide liquid and powder in the domestic market.
- Antidumping application in progress: Work is underway on applying for antidumping provisions; management believes that once fair pricing is established, the company can compete without issues.
Daga: "Once that is done then if there is a fair pricing then we are able to compete with a fair pricing without any issues."
Distribution Segment: Price Pressure, Margin Resilience
- Revenue declined on dual headwinds: Distribution revenue fell QoQ due to lower domestic demand, a downward trend in price realizations, and a dip in exports driven by recessionary pressures from the U.S. oil and gas sector.
- Margins improved despite the top-line fall: EBITDA for the distribution segment edged up from 6% to 6.42%, as a sharp fall in purchase costs offset the revenue decline.
- Supply constraints are easing: Key products such as Ethanolamine and Isophthalic acid are seeing supply constraints ease, which management expects will help the upcoming quarter.
- Domestic demand showing early pickup: After prolonged subdued exports, domestic demand is picking up, and stabilizing-to-rising prices are expected to augment both volume and revenue growth.
- Merchant export risk remains: The distribution sector is still under distress, which could adversely impact merchant export volumes even during the current quarter.
New Products & Projects: Building the Next Leg
- NMA gaining commercial traction: The product received approval from a foreign customer, new orders from a foreign multinational, and management expects approval from a key domestic customer within the quarter, all of which will add substantially to volume and sales.
- Polyacrylamide Solids development advancing: Substantial work on the recipe is complete; equipment development is now underway, with CapEx to be frozen once that crystallizes. The target market segment (water treatment) differs from the existing Indian competitor.
- PAM Solid ramp-up expected to be faster: Because these products have been part of the distribution portfolio and sold for years, management expects to reach significant utilization levels in a shorter span than a typical new product, though no exact timeline was given.
- Two toll manufacturing projects secured: Earned from U.S. and European companies, these projects relate to acrylamide chemistries and forward integration products, and will require CapEx despite spare capacity in the existing plant.
- Specialty chemical project with Japanese partner: In advanced stages of discussion; space at the Jhagadia site is already identified and earmarked, with a target timeline of early FY26, subject to fresh environmental clearance.
- Carboxylic acid requires no new investment: The facility is already available; only process development is needed, meaning no capital outlay for an additional product, revenue, and margin stream.
Jatia: "We would not be investing money in a plant if we are going to earn the same money by just buying and selling the product."
Margins: The Path Back to 10%
- Sharp QoQ recovery: EBITDA margin improved from 4.5% to 8.84%, driven by better spreads in manufacturing exports and improved distribution margins, despite lower distribution revenue.
- Raw material tailwind: A continuous fall in Acrylonitrile prices through the quarter improved the spread on price realization; prices hit their lowest in 1.5 years by quarter-end and have since stabilized and reversed upward to about $1050.
- Falling input costs offset revenue decline: The sharp fall in purchase costs and raw material prices from the manufacturing sector helped improve overall margins even as revenue dipped.
- Management targets 10% for the year: The company is striving to achieve about 10% margins for the full year, which it describes as the typical margin level, and expects to keep improving EBITDA percent in subsequent quarters.
Daga: "We are trying to again achieve about 10% margins for this year, which is the typical margin."
Competitive Dynamics & Capacity Philosophy
- Capacity utilization is not the guiding metric: Management explicitly stated that capacity utilization is not a significant aspect they track, because the capital cost of NMA (Rs. 1 crore) and acrylamide solid (Rs. 5 crores) is negligible; the focus is on maximizing sales and revenues.
- Margins are a function of production cost, not CapEx: When asked if low CapEx would mean higher margins on new products, management corrected the premise: margins depend on raw material and utilities cost, and acrylamide solid margins are comparable to liquids, not as good as NMA, due to competition.
- Chinese dumping timeline is unknowable: Management deflected when asked how long dumping would continue, calling it a difficult question to answer in terms of timeline.
Daga: "So, to be honest, it is a difficult question to answer in terms of timeline."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBITDA margin target | Achieve about 10% margins, the typical level | FY24 (current year) |
| Polyacrylamide Solids commercial launch | Technology development stage; equipment development underway | Target Q3 FY25 (not reconfirmed in this call) |
| Specialty chemical project with Japanese partner | Space identified at Jhagadia; fresh environmental clearance needed | Early FY26 |
| NMA domestic customer approval | Approval expected from a key domestic customer, adding substantially to volume and sales | Within the current quarter |
| Antidumping application | Work is in progress on applying for antidumping provision for Acrylamide | No timeline given |
Key Metrics
| Metric | Q1 FY24 |
|---|---|
| Revenue | ₹68.8 cr, slightly down QoQ but increased vs Q1 FY23 |
| EBITDA margin | 8.84%, improved from 4.5% in Q4 FY23 |
| Debt-to-equity ratio | 0.01, negligible |
| Exports share of sales | 45% of overall sales |
| Manufacturing segment revenue growth | ~13% QoQ, driven by Acrylamide Liquid exports |
| Manufacturing segment volume growth | 46% QoQ |
| Distribution segment EBITDA margin | 6.42%, improved from 6% in Q4 FY23 |
| Distribution top-5 products share of topline | ~80% of topline |
| Distribution top-5 products share of profit | >66% of profit |
| Acrylamide Liquid capacity utilization | 60%–70% |
| Acrylamide Solid capacity utilization | ~30% |
| Acrylamide Solid current price | ₹150–₹160 per kilo |
| Acrylonitrile price (raw material) | ~$1,050, up from mid-$900 levels at quarter start |
| Total CapEx outlay to date | ₹58 cr across products |
| PAM Solid commercial launch target | Q3 FY25 |